Scientists have developed a soft, wearable stethoscope that could make it easier to detect lung abnormalities that are indicative of…
Marisa Wexler, MS
Marisa holds a Master of Science in cellular and molecular pathology from the University of Pittsburgh, where she studied novel genetic drivers of ovarian cancer. Her areas of expertise include cancer biology, immunology, and genetics, and she has worked as a science writing and communications intern for the Genetics Society of America.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Marisa Wexler, MS
Enrollment is now complete in ENHANCE-1, a Phase 3 clinical trial testing Verona Pharma’s experimental inhalation therapy ensifentrine in more…
A first-in-human clinical trial testing the safety and tolerability of EP395, EpiEndo Pharmaceuticals’ experimental treatment for chronic obstructive…
Propeller Health has announced three new initiatives aiming to broaden the application of its technology, which connects a sensor…
Respira Labs has raised $2.8 million to help develop a wearable device that uses sound to evaluate lung function…
The U.S. Food and Drug Administration (FDA) has given final approval to Zydus Pharmaceuticals to start marketing roflumilast…
The U.S. Food and Drug Administration (FDA) has approved Lupin Limited’s generic form of Brovana (arformoterol tartrate) for…
Standardized questionnaires can effectively be used to help diagnose chronic obstructive pulmonary disease (COPD) in settings where healthcare resources…
An international team of researchers has published a new framework, dubbed the Rome proposal, for defining and classifying exacerbations of…
NuvoAir Aos, a sensor developed by NuvoAir that can track how inhalers are used by people with chronic…